EcoDrugPlus

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSDARG00000004877
Gene Symbol: ROCK2B
5 Cross references
209 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSDARG00000096433
Gene Symbol: ROCK2B
2 Cross references
209 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b, Like

Ensembl ID : ENSDARG00000100381
Gene Symbol: ROCK2BL
3 Cross references
209 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSDARG00000025581
Gene Symbol: RPL10
12 Enzyme and pathways 5 Cross references
408 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSDARG00000042905
Gene Symbol: RPL10A
12 Enzyme and pathways 5 Cross references
377 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSDARG00000043509
Gene Symbol: RPL11
12 Enzyme and pathways 5 Cross references
287 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSDARG00000006691
Gene Symbol: RPL12
12 Enzyme and pathways 5 Cross references
490 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSDARG00000099380
Gene Symbol: RPL13
12 Enzyme and pathways 5 Cross references
272 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSDARG00000044093
Gene Symbol: RPL13A
12 Enzyme and pathways 5 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSDARG00000103433
Gene Symbol: RPL14
12 Enzyme and pathways 5 Cross references
311 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSDARG00000009285
Gene Symbol: RPL15
12 Enzyme and pathways 5 Cross references
376 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSDARG00000057556
Gene Symbol: RPL17
12 Enzyme and pathways 5 Cross references
325 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).